patient report system new drugs pubmed

Do patients report symptoms due to a prescribed drug?

Aims: To develop a systematic generic method of enabling patients to report symptoms which they believe to be due to a particular prescribed drug. Methods: A piloted body system-based questionnaire was distributed to patients registered with 79 medical practices in Grampian prescribed one of nine recently marketed 'black triangle' drugs.

Does the national drug formulary system improve patient access to new drugs?

This study reviews and evaluates the national drug formulary system used to improve patient access to new drugs by making reimbursement decisions for new drugs as part of the South Korean national health insurance system.

How does the National Health Insurance Program improve patient access to drugs?

The national health insurance utilizes three methods for improving patient access to costly drugs: risk-sharing agreements, designation of essential drugs, and a waiver of cost-effectiveness analysis.

Do patients report adverse drug reactions (ADRs)?

Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report Lack of awareness of the ADR monitoring system is still prevalent among Malaysian patients. The ease of completing the ADR form and education level are predictive of patient confidence to report ADRs.

Abstract

Introduction: Patient reporting of adverse drug reactions (ADRs) to spontaneous reporting systems can make a valuable contribution to pharmacovigilance. However, the implementation and promotion of patient reporting systems (PRSs) differ worldwide.

MeSH terms

Adverse Drug Reaction Reporting Systems / statistics & numerical data*

How are drug prices determined?

If the drugs are found to be superior to their alternatives , the drug prices are determined based on a cost-effectiveness evaluation.

Why are pharmaceutical companies advocating for drug prices above certain thresholds?

However, pharmaceutical companies are advocating for drug prices above certain thresholds to maintain global pricing strategies, cover the costs of drug development, and fund future investments into research and development.

Why are some drugs not eligible for risk sharing agreement?

Although the risk-sharing agreement system was implemented to improve patient access to new drugs, some drugs are not eligible under this system because they are not considered cost-effective. In particular, evidence of cost-effectiveness could not be generated for anticancer agents or orphan drugs [31].

How does national health insurance help patients?

The national health insurance utilizes three methods for improving patient access to costly drugs: risk-sharing agreements, designation of essential drugs, and a waiver of cost-effectiveness analysis.

What percentage of GDP is spent on health in South Korea?

Public health expenditure in South Korea accounts for 7.4% of its gross domestic product (GDP). In general, health expenditure increases as a function of income, which means that Organization for Economic Co-operation and Development (OECD) nations with high GDPs per capita tend to have high health expenditures.

Is a drug not reimbursable?

If a pharmaceutical company does not agree to the price of a drug suggested by the NHIS, the drug is not listed as non-reimbursable. In this instance, the reimbursement adjustment committee under the Ministry of Health and Welfare reviews the case, and they may ultimately list the drug as reimbursable.